Fludarabine Phosphate
fludarabine phosphate
Fludarabine Phosphate for Injection treats adult patients with B-cell chronic lymphocytic leukemia (CLL) who have not responded to or whose disease has progressed during treatment with at least one standard alkylating-agent containing regimen.
Form
Tablet
Uses
1
Side effects
4
Category
Oncology
What is Fludarabine Phosphate used for?
- Fludarabine Phosphate for Injection is indicated for the treatment of adult patients with B-cell chr
fludarabine phosphate side effects
The following side effects have been reported for fludarabine phosphate. Their order does not indicate how often an effect occurs.
fludarabine phosphate warnings & precautions
- (See BOXED WARNINGS ) Dose Dependent Neurologic Toxicities There are clear dose-dependent toxic effects seen with Fludarabine Phosphate for Injection.
- Dose levels approximately 4 times greater (96 mg/m 2 /day for 5 to 7 days) than that recommended for CLL (25 mg/m 2 /day for 5 days) were associated w
- Symptoms appeared from 21 to 60 days following the last dose.
Loading FDA data…
Frequently asked questions
Related medications
Share this drug info.
Help friends and family understand Fludarabine Phosphate in plain language.
Disclaimer: This information is sourced from the FDA openFDA database and is provided for educational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your physician or pharmacist before starting or changing medication.